Ati cautat: recomandari medicamente
Consiliul Concurentei a declansat o ancheta pe piata de retail farmaceutic din Romania
Protocol terapeutic: R07AX02 – DCI IVACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N07XX12 – DCI PATISIRANUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AX04 – DCI LENALIDOMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L02BB05 – DCI APALUTAMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX71 – DCI TISAGENLECLEUCEL (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AX18 – DCI LETERMOVIRUM (forma orală) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: D11AH05 – DCI DUPILUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB03 – DCI AGALSIDASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: R07AX30 – DCI LUMACAFTORUM+IVACAFTORUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
